These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 24641205)

  • 1. Human IgG antibody response to Aedes aegypti Nterm-34 kDa salivary peptide as an indicator to identify areas at high risk for dengue transmission: a retrospective study in urban settings of Vientiane city, Lao PDR.
    Ndille EE; Dubot-Pérès A; Doucoure S; Mouchet F; Cornelie S; Sidavong B; Fournet F; Remoue F
    Trop Med Int Health; 2014 May; 19(5):576-80. PubMed ID: 24641205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aedes aegypti anti-salivary gland antibody concentration and dengue virus exposure history in healthy individuals living in an endemic area in Colombia.
    Londoño-Rentería B; Cárdenas JC; Giovanni JE; Cárdenas L; Villamizar P; Rolón J; Chisenhall DM; Christofferson RC; Carvajal DJ; Pérez OG; Wesson DM; Mores CN
    Biomedica; 2015; 35(4):572-81. PubMed ID: 26844447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human IgG Antibody Response to Aedes Nterm-34kDa Salivary Peptide, an Epidemiological Tool to Assess Vector Control in Chikungunya and Dengue Transmission Area.
    Elanga Ndille E; Doucoure S; Poinsignon A; Mouchet F; Cornelie S; D'Ortenzio E; DeHecq JS; Remoue F
    PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005109. PubMed ID: 27906987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spatial distribution and risk factors of dengue and Japanese encephalitis virus infection in urban settings: the case of Vientiane, Lao PDR.
    Vallée J; Dubot-Pérès A; Ounaphom P; Sayavong C; Bryant JE; Gonzalez JP
    Trop Med Int Health; 2009 Sep; 14(9):1134-42. PubMed ID: 19563430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First attempt to validate human IgG antibody response to Nterm-34kDa salivary peptide as biomarker for evaluating exposure to Aedes aegypti bites.
    Elanga Ndille E; Doucoure S; Damien G; Mouchet F; Drame PM; Cornelie S; Noukpo H; Yamadjako S; Djenontin A; Moiroux N; Misse D; Akogbeto M; Corbel V; Henry MC; Chandre F; Baldet T; Remoue F
    PLoS Negl Trop Dis; 2012; 6(11):e1905. PubMed ID: 23166852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serological biomarker for assessing human exposure to Aedes mosquito bites during a randomized vector control intervention trial in northeastern Thailand.
    Fustec B; Phanitchat T; Aromseree S; Pientong C; Thaewnongiew K; Ekalaksananan T; Cerqueira D; Poinsignon A; Elguero E; Bangs MJ; Alexander N; Overgaard HJ; Corbel V
    PLoS Negl Trop Dis; 2021 May; 15(5):e0009440. PubMed ID: 34043621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human IgG responses to Aedes mosquito salivary peptide Nterm-34kDa and its comparison to Anopheles salivary antigen (gSG6-P1) IgG responses measured among individuals living in Lower Moshi, Tanzania.
    Kassam NA; Laswai D; Kulaya N; Kaaya RD; Kajeguka DC; Schmiegelow C; Wang CW; Alifrangis M; Kavishe RA
    PLoS One; 2022; 17(10):e0276437. PubMed ID: 36301860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spatial Assessment of Contact Between Humans and Anopheles and Aedes Mosquitoes in a Medium-Sized African Urban Setting, Using Salivary Antibody-Based Biomarkers.
    Sagna AB; Kassié D; Couvray A; Adja AM; Hermann E; Riveau G; Salem G; Fournet F; Remoue F
    J Infect Dis; 2019 Aug; 220(7):1199-1208. PubMed ID: 31152664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune reactivity to dengue and Aedes albopictus mosquitoes in the population from Macao, China, before dengue occurrence.
    De Carvalho IL; Rocha DK; Almeida AP
    In Vivo; 2011; 25(4):625-31. PubMed ID: 21709006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of anti-Aedes aegypti salivary extract antibody concentration to correlate risk of vector exposure and dengue transmission risk in Colombia.
    Londono-Renteria B; Cardenas JC; Cardenas LD; Christofferson RC; Chisenhall DM; Wesson DM; McCracken MK; Carvajal D; Mores CN
    PLoS One; 2013; 8(12):e81211. PubMed ID: 24312537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to
    Chea S; Willen L; Nhek S; Ly P; Tang K; Oristian J; Salas-Carrillo R; Ponce A; Leon PCV; Kong D; Ly S; Sath R; Lon C; Leang R; Huy R; Yek C; Valenzuela JG; Calvo E; Manning JE; Oliveira F
    Front Immunol; 2024; 15():1368066. PubMed ID: 38751433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgG1 and IgG4 antibodies against Aedes aegypti salivary proteins and risk for dengue infections.
    Cardenas JC; Drame PM; Luque-Burgos KA; Berrio JD; Entrena-Mutis E; González MU; Carvajal DJ; Gutiérrez-Silva LY; Cardenas LD; Colpitts TM; Mores CN; Londono-Renteria B
    PLoS One; 2019; 14(1):e0208455. PubMed ID: 30601814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of dengue virus infection in US travelers who have lived in or traveled to dengue-endemic countries.
    Sanchez-Vegas C; Hamer DH; Chen LH; Wilson ME; Benoit C; Hunsperger E; Macleod WB; Jentes ES; Ooi WW; Karchmer AW; Kogelman L; Yanni E; Marano N; Barnett ED
    J Travel Med; 2013; 20(6):352-60. PubMed ID: 24165381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the heterogeneity of human exposure to malaria vectors in an urban setting, Bouaké, Côte d'Ivoire, using an immuno-epidemiological biomarker.
    Traoré DF; Sagna AB; Adja AM; Zoh DD; Adou KA; Lingué KN; Coulibaly I; Tchiekoi NB; Assi SB; Poinsignon A; Dagnogo M; Remoue F
    Malar J; 2019 Mar; 18(1):68. PubMed ID: 30857543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgG responses to the gSG6-P1 salivary peptide for evaluating human exposure to Anopheles bites in urban areas of Dakar region, Sénégal.
    Drame PM; Machault V; Diallo A; Cornélie S; Poinsignon A; Lalou R; Sembène M; Dos Santos S; Rogier C; Pagès F; Le Hesran JY; Remoué F
    Malar J; 2012 Mar; 11():72. PubMed ID: 22424570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific human antibody responses to Aedes aegypti and Aedes polynesiensis saliva: A new epidemiological tool to assess human exposure to disease vectors in the Pacific.
    Mathieu-Daudé F; Claverie A; Plichart C; Boulanger D; Mphande FA; Bossin HC
    PLoS Negl Trop Dis; 2018 Jul; 12(7):e0006660. PubMed ID: 30040826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary validation of the use of IgG antibody response to Anopheles gSG6-p1 salivary peptide to assess human exposure to malaria vector bites in two endemic areas of Cameroon in Central Africa.
    Cheteug G; Elanga-Ndille E; Donkeu C; Ekoko W; Oloume M; Essangui E; Nwane P; NSango SE; Etang J; Wanji S; Ayong L; Eboumbou Moukoko CE
    PLoS One; 2020; 15(12):e0242510. PubMed ID: 33382730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human antibody response to Aedes aegypti saliva in an urban population in Bolivia: a new biomarker of exposure to Dengue vector bites.
    Doucoure S; Mouchet F; Cournil A; Le Goff G; Cornelie S; Roca Y; Giraldez MG; Simon ZB; Loayza R; Misse D; Flores JV; Walter A; Rogier C; Herve JP; Remoue F
    Am J Trop Med Hyg; 2012 Sep; 87(3):504-10. PubMed ID: 22848099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis in a murine model points to IgG responses against the 34k2 salivary proteins from Aedes albopictus and Aedes aegypti as novel promising candidate markers of host exposure to Aedes mosquitoes.
    Buezo Montero S; Gabrieli P; Severini F; Picci L; Di Luca M; Forneris F; Facchinelli L; Ponzi M; Lombardo F; Arcà B
    PLoS Negl Trop Dis; 2019 Oct; 13(10):e0007806. PubMed ID: 31618201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Households as foci for dengue transmission in highly urban Vietnam.
    Anders KL; Nga le H; Thuy NT; Ngoc TV; Tam CT; Tai LT; Truong NT; Duyen HT; Trung VT; Kien DT; Wolbers M; Wills B; Chau NV; Tho ND; Simmons CP
    PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003528. PubMed ID: 25680106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.